Healthcare Industry Sevoflurane, Isoflurane and Desflurane Market | Page 3

Hexa Research Fact-based market research, penetrating industry insights and validated forecasts to help you make better decisions for a stronger future Isoflurane Isoflurane is a halogen ether utilized frequently by veterinarians. It is administered intravenously, relaxes the muscles and reduces pain. Isoflurane has also been used for inducing sleepiness for long durations during surgery. It is expected to register a CAGR of about 10% by 2022. Desflurane Desflurane is a halogen ether used in general anesthesia. Its effectiveness is one-fifth of isoflurane. Desflurane cannot be administered orally and requires an electrically heated dispenser to distribute the vapor. It is mostly administered to bariatric patients and in cases of surgeries lasting for short durations. Regional Overview The United States has a large geriatric population. This has led the region of North America to occupy the biggest share in the worldwide inhalation anesthesia market in 2014. Surgical ambulatory and inpatient procedures are the driving factors of North America. Asia Pacific will experience the fastest growth by 2022. This is owing to the rise of chronic diseases and need for better health infrastructure in the region. Medical tourism combined with insurance coverage will play a huge role in sustaining the growth of the sevoflurane, isoflurane and desflurane market. Key Players The market is currently dominated by AbbVie and Baxter International. However, it can expect strong competition from manufacturers like Lunan Pharmaceutical Group and Piramal Enterprises. Contact: [phone] Email : [email protected] Website: http://www.hexaresearch.com/